C19orf67
gene geneOn this page
Summary
C19orf67 (chromosome 19 open reading frame 67, HGNC:34354) is a protein-coding gene on chromosome 19p13.12, encoding UPF0575 protein C19orf67 (A6NJJ6).
Predicted to act upstream of or within in utero embryonic development.
Source: NCBI Gene 646457 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001277378
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34354 |
| Approved symbol | C19orf67 |
| Name | chromosome 19 open reading frame 67 |
| Location | 19p13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000188032 |
| Ensembl biotype | protein_coding |
| Entrez | 646457 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000343945, ENST00000547589, ENST00000548523
RefSeq mRNA: 1 — MANE Select: NM_001277378
NM_001277378
CCDS: CCDS59360
Canonical transcript exons
ENST00000548523 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001366162 | 14083505 | 14083605 |
| ENSE00001381312 | 14085293 | 14085783 |
| ENSE00001382182 | 14082469 | 14082603 |
| ENSE00001387859 | 14083237 | 14083422 |
| ENSE00002415488 | 14081624 | 14082008 |
| ENSE00003568840 | 14083733 | 14083877 |
Expression profiles
Bgee: expression breadth broad, 72 present calls, max score 84.06.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0201 / max 11.9482, expressed in 4 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179598 | 0.0201 | 4 |
Top tissues by expression
88 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.06 | silver quality |
| left testis | UBERON:0004533 | 69.29 | gold quality |
| testis | UBERON:0000473 | 68.64 | gold quality |
| right testis | UBERON:0004534 | 66.62 | gold quality |
| bone marrow cell | CL:0002092 | 52.95 | gold quality |
| placenta | UBERON:0001987 | 50.83 | gold quality |
| right uterine tube | UBERON:0001302 | 50.49 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 48.10 | gold quality |
| sural nerve | UBERON:0015488 | 45.45 | gold quality |
| cortex of kidney | UBERON:0001225 | 45.31 | silver quality |
| right coronary artery | UBERON:0001625 | 45.26 | gold quality |
| endocervix | UBERON:0000458 | 44.68 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 44.05 | silver quality |
| stomach | UBERON:0000945 | 43.82 | gold quality |
| metanephros cortex | UBERON:0010533 | 43.78 | gold quality |
| body of stomach | UBERON:0001161 | 43.62 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 43.37 | silver quality |
| bone marrow | UBERON:0002371 | 43.11 | gold quality |
| granulocyte | CL:0000094 | 43.06 | silver quality |
| body of pancreas | UBERON:0001150 | 42.60 | silver quality |
| transverse colon | UBERON:0001157 | 42.48 | gold quality |
| kidney | UBERON:0002113 | 42.17 | silver quality |
| fundus of stomach | UBERON:0001160 | 41.92 | gold quality |
| uterine cervix | UBERON:0000002 | 41.83 | silver quality |
| right lobe of thyroid gland | UBERON:0001119 | 41.74 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.71 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 41.57 | gold quality |
| urinary bladder | UBERON:0001255 | 41.16 | gold quality |
| minor salivary gland | UBERON:0001830 | 41.13 | silver quality |
| myometrium | UBERON:0001296 | 40.93 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
4 targeting C19orf67, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-4313 | 97.18 | 63.15 | 420 |
| HSA-MIR-6068 | 92.95 | 63.01 | 67 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-214c7.5 | ENSDARG00000060187 |
| mus_musculus | 1700067K01Rik | ENSMUSG00000046408 |
| rattus_norvegicus | C19h19orf67 | ENSRNOG00000005533 |
Protein
Protein identifiers
UPF0575 protein C19orf67 — A6NJJ6 (reviewed: A6NJJ6)
All UniProt accessions (2): A6NJJ6, A0A0A0MRA4
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the UPF0575 family.
RefSeq proteins (1): NP_001264307* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021748 | DUF3314 | Family |
Pfam: PF11771
UniProt features (4 total): compositionally biased region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NJJ6-F1 | 73.54 | 0.40 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 24 (showing top):
GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT, GOBP_EMBRYO_DEVELOPMENT, chr19p13, MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED, MEISSNER_NPC_HCP_WITH_H3K4ME2, MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED, MARTENS_TRETINOIN_RESPONSE_UP, GLI1_TARGET_GENES, GSE13306_TREG_RA_VS_TCONV_RA_UP, GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP, MEF2C_TARGET_GENES, NCOA4_TARGET_GENES, MYOCD_TARGET_GENES, GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
164 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C19orf67 | C19orf53 | Q9UNZ5 | 584 |
| C19orf67 | YJU2B | P13994 | 542 |
| C19orf67 | BRME1 | Q0VDD7 | 541 |
| C19orf67 | ZSWIM4 | Q9H7M6 | 477 |
| C19orf67 | PALM3 | A6NDB9 | 476 |
| C19orf67 | PODNL1 | Q6PEZ8 | 474 |
| C19orf67 | SAMD1 | Q6SPF0 | 471 |
| C19orf67 | SLC67A1-AS | Q8N1D0 | 419 |
| C19orf67 | ADGRE3 | Q9BY15 | 418 |
| C19orf67 | DCAF15 | Q66K64 | 400 |
| C19orf67 | MRI1 | Q9BV20 | 397 |
| C19orf67 | ANO10 | Q9NW15 | 380 |
| C19orf67 | RIT2 | Q99578 | 380 |
| C19orf67 | CC2D1A | Q6P1N0 | 375 |
| C19orf67 | NREP | Q16612 | 371 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GVZ6, A0A1W2PR82, A0A286YDK6, A2A9F4, A2VE02, A5D7I0, A6H7B4, A6NE82, A6NEV1, A6NJB7, A6NJI1, A6NJJ6, A6QP24, A6QPM6, A8MZG2, D3ZAQ5, D4AAA5, O94850, O95873, P0C7X2, P50617, P70339, Q0P5M0, Q2KIL8, Q2KIS6, Q3UN58, Q3ZCQ2, Q5JPB2, Q5M844, Q5VZ46, Q6AY88, Q6GQX2, Q6NZ36, Q6ZW13, Q76NI1, Q7TNS8, Q80TS7, Q86YN6, Q8C1M2, Q8K2F3
Diamond homologs: A3KNM4, A6NJJ6, Q8CF25
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1035 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:14082484:T:TA | donor_gain | 1.0000 |
| 19:14083235:A:AC | donor_gain | 1.0000 |
| 19:14083236:C:CG | donor_gain | 1.0000 |
| 19:14083236:CTA:C | donor_gain | 1.0000 |
| 19:14083236:CTAAT:C | donor_gain | 1.0000 |
| 19:14083285:T:TA | donor_gain | 1.0000 |
| 19:14083403:C:CT | acceptor_gain | 1.0000 |
| 19:14083403:C:T | acceptor_gain | 1.0000 |
| 19:14083421:TG:T | acceptor_gain | 1.0000 |
| 19:14083423:C:CC | acceptor_gain | 1.0000 |
| 19:14083601:AACAG:A | acceptor_gain | 1.0000 |
| 19:14083602:ACAG:A | acceptor_gain | 1.0000 |
| 19:14083603:CAG:C | acceptor_gain | 1.0000 |
| 19:14083603:CAGC:C | acceptor_gain | 1.0000 |
| 19:14083604:AG:A | acceptor_gain | 1.0000 |
| 19:14083606:C:CC | acceptor_gain | 1.0000 |
| 19:14083606:CT:C | acceptor_loss | 1.0000 |
| 19:14083609:C:CT | acceptor_gain | 1.0000 |
| 19:14083610:A:AC | acceptor_gain | 1.0000 |
| 19:14083610:A:C | acceptor_gain | 1.0000 |
| 19:14083613:C:CT | acceptor_gain | 1.0000 |
| 19:14083614:A:T | acceptor_gain | 1.0000 |
| 19:14083724:T:TA | donor_gain | 1.0000 |
| 19:14083731:AC:A | donor_gain | 1.0000 |
| 19:14083732:CC:C | donor_gain | 1.0000 |
| 19:14083749:T:TA | donor_gain | 1.0000 |
| 19:14082463:TCCTA:T | donor_loss | 0.9900 |
| 19:14082464:CCTA:C | donor_loss | 0.9900 |
| 19:14082465:CTACC:C | donor_loss | 0.9900 |
| 19:14082466:TACCA:T | donor_loss | 0.9900 |
AlphaMissense
2282 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:14082524:A:G | W283R | 0.999 |
| 19:14082524:A:T | W283R | 0.999 |
| 19:14083295:A:G | W237R | 0.999 |
| 19:14083295:A:T | W237R | 0.999 |
| 19:14082509:A:G | W288R | 0.998 |
| 19:14082509:A:T | W288R | 0.998 |
| 19:14082521:A:G | S284P | 0.997 |
| 19:14083293:C:A | W237C | 0.997 |
| 19:14083293:C:G | W237C | 0.997 |
| 19:14082522:C:A | W283C | 0.996 |
| 19:14082522:C:G | W283C | 0.996 |
| 19:14083294:C:G | W237S | 0.996 |
| 19:14083305:C:A | K233N | 0.996 |
| 19:14083305:C:G | K233N | 0.996 |
| 19:14083402:C:T | G201E | 0.996 |
| 19:14083403:C:A | G201W | 0.996 |
| 19:14081922:A:G | L330P | 0.995 |
| 19:14082507:C:A | W288C | 0.995 |
| 19:14082507:C:G | W288C | 0.995 |
| 19:14083583:A:G | L168P | 0.995 |
| 19:14082514:C:T | G286D | 0.994 |
| 19:14082517:A:T | I285N | 0.994 |
| 19:14083562:A:G | L175P | 0.994 |
| 19:14081946:G:T | P322H | 0.993 |
| 19:14082591:G:C | C260W | 0.993 |
| 19:14082593:A:G | C260R | 0.993 |
| 19:14083395:G:C | F203L | 0.993 |
| 19:14083395:G:T | F203L | 0.993 |
| 19:14083397:A:G | F203L | 0.993 |
| 19:14083402:C:A | G201V | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000194596 (19:14086152 C>G), RS1000527823 (19:14086342 T>A), RS1000562963 (19:14083278 G>A), RS1000726785 (19:14086197 T>C), RS1000847630 (19:14083548 C>T), RS1001726952 (19:14082901 A>C), RS1002260049 (19:14081658 C>T), RS1002581452 (19:14085834 C>T), RS1003081758 (19:14087370 C>G), RS1003130977 (19:14087589 A>G), RS1003291554 (19:14081469 C>A,T), RS1003311542 (19:14082939 G>A), RS1003407527 (19:14081208 C>T), RS1003994790 (19:14087111 T>C), RS1004407800 (19:14086085 ATTTT>A,ATTTTT)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.